Barts-MS Journal Club Dr Aboulwafa
Channel: Gavin Giovannoni
Date: 26/08/2020

Dr Mohammad Aboulwafa discusses the MS-Base analysis looking at early vs. late and low vs. high-efficacy DMTs. Does this paper change the field of MS? 

He A, Merkel B, Brown JWL, et al. Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study. Lancet Neurol. 2020;19(4):307-316. doi:10.1016/S1474-4422(20)30067-3